The economics of the new (effective) weight loss drugs.
Semaglutides came on the scene after last year’s FDA approval. “Until now, doctors didn’t really use medication to treat obesity; the drugs either didn’t work or had too many side effects. … Semaglutide marks the start of a new generation of weight loss drugs that are more clearly worthwhile.” | learn more